Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 4Sarcoidosis, Pulmonary 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pentoxifylline, Cisplatin, Nephrotoxixcity 1Pancreatitis, Alcoholic 1Pancreatitis 1Pain 1Neoplasms 1Mucositis 1Lymphedema 1Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1Head and Neck Neoplasms 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Fibrosis 1Erectile Dysfunction 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Cachexia 1Breast Neoplasms, Male 1Brain Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Cisplatin 150Radiotherapy 121Cetuximab 96Docetaxel 60Fluorouracil 56Paclitaxel 45Radiotherapy, Intensity-Modulated 41Carboplatin 40pembrolizumab 34Surveys and Questionnaires 22Erlotinib Hydrochloride 19Nivolumab 18Immunohistochemistry 16Gefitinib 16Drug Therapy 16Gemcitabine 14Pemetrexed 13Gene Expression Profiling 13durvalumab 12Chemotherapy, Adjuvant 12Radiation 11Filgrastim 11Bevacizumab 11Surgical Procedures, Operative 10Polymerase Chain Reaction 10Amifostine 10Celecoxib 9Capecitabine 9Standard of Care 8Neoadjuvant Therapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Head and Neck Neoplasms × Pentoxifylline × Clear all
NCT02397486 2019-11-26

The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients

Ain Shams University

Phase 2 Completed
60 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡